Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuronal death in glaucoma

H A Quigley1

  • 1Glaucoma Service and the Dana Center for Preventive Ophthalmology, Wilmer Inst., Johns Hopkins University School of Medicine, Baltimore, MD 21287-9205, USA.

Progress in Retinal and Eye Research
|January 27, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective loss of pattern discrimination in early glaucoma.

Applied optics·2010
Same author

Effect of cataract on a scotopic sensitivity screening test for glaucoma.

Journal of glaucoma·2009
Same author

The number of people with glaucoma worldwide in 2010 and 2020.

The British journal of ophthalmology·2006
Same author

Parafoveal retinal telangiectasis: light and electron microscopy studies. 1977.

Retina (Philadelphia, Pa.)·2005
Same author

New paradigms in the mechanisms and management of glaucoma.

Eye (London, England)·2004
Same author

Gene therapy for optic nerve disease.

Eye (London, England)·2004
Same journal

Visual arrestin-1: how did we learn what we know today about this protein?

Progress in retinal and eye research·2026
Same journal

Transcending Genome-Wide Association Studies to Create Useful Multi-omic Views of Glaucoma.

Progress in retinal and eye research·2026
Same journal

Cutting-edge cross-linking biomaterials advancing ophthalmic therapeutics.

Progress in retinal and eye research·2026
Same journal

Scleral remodeling in myopia: mechanisms and therapeutic approaches.

Progress in retinal and eye research·2026
Same journal

Macular fibrosis secondary to neovascular age-related macular degeneration: from clinic to biology.

Progress in retinal and eye research·2026
Same journal

Stromal Transplantation and corneal-sparing techniques in ectatic diseases.

Progress in retinal and eye research·2026
See all related articles

Glaucoma damages the eye by killing retinal ganglion cells, primarily at the optic nerve head, linked to intraocular pressure. Understanding this cell death mechanism, including apoptosis, is key for developing new glaucoma therapies.

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Cell Biology

Background:

  • Glaucoma is a leading cause of vision loss, characterized by retinal ganglion cell death.
  • Cell death in glaucoma is initiated at the optic nerve head, influenced by intraocular pressure.
  • Regional variations in connective tissue structure at the optic nerve head correlate with differential ganglion cell loss.

Purpose of the Study:

  • To elucidate the mechanisms of retinal ganglion cell death in glaucoma.
  • To explore the role of optic nerve head structure and intraocular pressure in glaucoma pathogenesis.
  • To identify potential therapeutic targets for neuroprotection in glaucoma.

Main Methods:

  • Review of existing literature on glaucoma pathophysiology.
  • Analysis of studies investigating optic nerve head biomechanics and cellular responses.

Related Experiment Videos

  • Examination of evidence for apoptosis as the mode of cell death in glaucoma.

    • Main Results:

    • Retinal ganglion cell death is a hallmark of glaucoma, with initiation at the optic nerve head.
    • Intraocular pressure is a significant factor, but the precise mechanism of injury remains unclear.
    • Larger retinal ganglion cells exhibit greater susceptibility, and cell death occurs via apoptosis.

    Conclusions:

    • Apoptosis of retinal ganglion cells presents therapeutic opportunities for glaucoma treatment.
    • Neurotrophin deprivation is a potential pathway leading to cell death.
    • Future therapies may involve neurotrophin replacement to protect retinal ganglion cells.